2021-09-09
临床阶段基因治疗疗法研发商
医药研发/制造
化学&生物药
Eventide Asset Management;
Eventide Asset Management;
D1 Capital Partners;
D1 Capital Partners;
Alexandria Venture Investments;
Invus;
Woodline Partners;
Janus Henderson Investors;
PBM Capital Group;
Lundbeckfonden Ventures;
Omega Funds;
Longitude Capital;
Gray's Creek Capital Partners;
Laurion Capital Management;
Verition Fund Management;
CAM Capital
2021-01-07
临床阶段基因治疗疗法研发商
医药研发/制造
化学&生物药
Omega Funds;
Omega Funds;
Longitude Capital;
Longitude Capital;
Alexandria Venture Investments;
Alzheimer's Drug Discovery Foundation;
Woodline Partners;
Invus;
Janus Henderson Investors;
PBM Capital Group;
Lundbeckfonden Ventures
2020-12-09
遗传性线粒体疾病治疗用生物新药研发商
医药研发/制造
化学&生物药
Amzak Health Investors;
Amzak Health Investors;
Pappas Capital;
Pappas Capital;
诺和诺德;
Aisling Capital;
Lundbeckfonden Ventures;
Abingworth;
New Enterprise Associate;
Rock Springs Capital;
RiverVest
2020-07-08
治疗性蛋白质研发商
医药研发/制造
化学&生物药
BioGeneration Ventures;
BioGeneration Ventures;
Ysios Capital Partners;
Ysios Capital Partners;
Lundbeckfonden Ventures;
InnovationQuarter;
Inkef;
Life Sciences Partners
2020-05-20
广谱抗真菌药研发商
医药研发/制造
化学&生物药
3×5 Partners;
3×5 Partners;
Pappas Capital;
Pappas Capital;
BioMed Ventures;
Sofinnova Partners;
辉瑞;
Lundbeckfonden Ventures;
Adage Capital Management;
New Enterprise Associate;
Arix Bioscience;
RiverVest
2019-06-26
血管钙化疾病治疗药物研发商
医药研发/制造
化学&生物药
HealthEquity;
HealthEquity;
Alta Life Sciences;
Alta Life Sciences;
Ysios Capital Partners;
Columbus Venture Partners;
Lundbeckfonden Ventures;
Andera Partners;
Gilde Healthcare;
Forbion Capital Partners;
Caixa Capital Risc
2019-05-20
遗传性线粒体疾病治疗用生物新药研发商
医药研发/制造
化学&生物药
Lundbeckfonden Ventures;
Lundbeckfonden Ventures;
New Enterprise Associate;
New Enterprise Associate;
RiverVest;
Pappas Capital
2018-01-04
免疫调节药物研发商
医药研发/制造
化学&生物药
Omnes Capital;
Omnes Capital;
Health for Life Capital fund;
Health for Life Capital fund;
Seventure Partners;
百时美施贵宝;
European Investment Bank （EIB）;
Lundbeckfonden Ventures;
Nestlé Health Science;
Principia SGR
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
